Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.72 |
| ▸ | IDE | P14735 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 13/20 | 0.50 |
| ▸ | MEN1 | O00255 | 11/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 9/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.49 |
| ▸ | LMNA | P02545 | 6/20 | 0.49 |
| ▸ | TP53 | P04637 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL192884 | 1.00 | MYC (0.72) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL5435126 | 0.90 | MYC (0.62) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL25289292 | 0.89 | MYC (0.68) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL29425687 | 0.89 | MYC (0.68) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL16983234 | 0.87 | MYC (0.74) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL29383084 | 0.84 | MYC (0.66) | MYCIDEMAPTMEN1KMT2A | |
| SCHEMBL9108408 | 0.84 | MYC (0.66) | MYCIDEMAPTMEN1KMT2A | |
| Methyl Red SCHEMBL343366 | 0.84 | MYC (1.00) | MYCIDEMAPTMEN1KMT2A | |
| Methyl Red SCHEMBL51823 | 0.84 | MYC (1.00) | MYCIDEMAPTMEN1KMT2A | |
| Methyl Red SCHEMBL30182635 | 0.84 | MYC (1.00) | MYCIDEMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101204357-B | Cosmetic product for dry-dyeing hair, applications and method of using same | OU LAIYA | 2012-07-18 | — | — | CN | claimed |
| EP-1855643-B1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | OREAL (FR) | 2011-08-03 | — | — | EP | claimed |
| US-7722680-B2 | Dyeing of human keratin materials by dry thermal transfer of a direct dye, composition comprising the said dye and its method of preparation | L'OREAL S.A. (FR) | 2010-05-25 | — | — | US | claimed |
| US-7611545-B2 | Cosmetic article and process for dry dyeing keratin materials | L'OREAL S.A. (FR) | 2009-11-03 | — | — | US | claimed |
| US-20080244837-A1 | Cosmetic article and process for dry dyeing keratin materials | L'OREAL S.A. (FR) | 2008-10-09 | — | — | US | claimed |
| EP-1964539-A1 | Cosmetic article for dyeing dry hair, its use, method of implementing said article | L'Oréal (FR) | 2008-09-03 | — | — | EP | claimed |
| US-20080148496-A1 | Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation | L'OREAL S.A. (FR) | 2008-06-26 | — | — | US | claimed |
| CN-101204357-A | Cosmetic product for dry-dyeing hair, applications and method of using same | OREAL (FR) | 2008-06-25 | — | — | CN | claimed |
| EP-1855643-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'OREAL (FR) | 2007-11-21 | — | — | EP | claimed |
| WO-2006089806-A1 | DYEING OF IN PARTICULAR HUMAN KERATIN MATERIALS BY DRY THERMAL TRANSFER OF A DIRECT DYE, COMPOSITION COMPRISING THE SAID DYE AND ITS METHOD OF PREPARATION | L'ORÉAL (FR) | 2006-08-31 | — | — | WO | claimed |
| US-5618733-A | IONIC SURFACTANT FOR LYSING ERYTHROCYTES AND CAUSING DAMAGE TO LEUKOCYTE CELL MEMBRANES, ORGANIC COMPOUND HAVING ACIDIC GROUP | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1997-04-08 | — | — | US | claimed |
| WO-2025031588-A1 | CURABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2025-02-13 | — | — | WO | disclosed |
| EP-4347032-A1 | SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | Vertex Pharmaceuticals Incorporated (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022256702-A1 | SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-12-08 | — | — | WO | disclosed |
| US-20200352795-A1 | WETNESS INDICATOR WITH HARDENERS | SAVARE' I.C. S.R.L. (IT) | 2020-11-12 | — | — | US | disclosed |
| WO-1999038902-A1 | COLOR INDICATOR FOR COMPLETION OF POLYMERIZATION FOR THERMOSETS | ALPHA METALS, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| US-5677183-A | MIXING WITH IONIC AND NONIONIC SURFACTANTS, ANIONIC ORGANIC COMPOUNDS AND BUFFERS TO LYSE ERYTHROCYTES AND DAMAGE PART OF LEUKOCYTE CELL MEMBRANE TO ALLOW BINDING TO ANIONIC MATERIAL FOR DETECTION AND MEASUREMENT | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5618733-A | IONIC SURFACTANT FOR LYSING ERYTHROCYTES AND CAUSING DAMAGE TO LEUKOCYTE CELL MEMBRANES, ORGANIC COMPOUND HAVING ACIDIC GROUP | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1997-04-08 | — | — | US | disclosed |
| EP-0695936-A2 | A method for classifying and counting leukocytes | TOA MEDICAL ELECTRONICS CO., Ltd. (JP) | 1996-02-07 | — | — | EP | disclosed |
| EP-0660113-A2 | A reagent for analyzing leucocytes | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1995-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080244837-A1 | Cosmetic article and process for dry dyeing keratin materials | KRT18, CUTA, DSG1 | MYC 3166/4885IDE 3080/4885MAPT 559/4885 |
| US-20080148496-A1 | Dyeing of in Particular Human Keratin Materials by Dry Thermal Transfer of a Direct Dye, Composition Comprising the Said Dye and Its Method of Preparation | KRT18, IK, DSG1 | MYC 3750/4885IDE 1818/4885MAPT 275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.